• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The new vaccine development by the fusion molecules of Ag85B and mycolic acid

Research Project

Project/Area Number 25860332
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Bacteriology (including mycology)
Research InstitutionJapan BCG Laboratory

Principal Investigator

KIYOHARA (KOHAMA) Hideyasu  日本ビーシージー製造株式会社(日本BCG研究所), その他部局等, 研究員 (10514581)

Project Period (FY) 2013-04-01 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2014: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2013: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Keywords結核 / 組換えタンパク / 脂質 / ワクチン
Outline of Final Research Achievements

In this study, we aimed to elicit an immune activating ability of Ag85B and mycolic acid (MA). In the natural state, Ag85B and MA were in the relationship between the enzyme and the substrate. Therefore we tried to mimic this Ag85B-MA fusion molecule which was thought to the best characteristics of both molecules, and tried to use for the development of new tuberculosis vaccine candidate. As a result, antigen and adjuvant combinations of enzymes (Ag85B) and substrate (MA), as compared to other common antigens (OVA) and MA, were resulting in higher antibody-inducing ability.

Report

(3 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • Research Products

    (1 results)

All 2015

All Presentation (1 results)

  • [Presentation] BCG細胞壁成分アジュバント活性に関する研究2015

    • Author(s)
      清原秀泰
    • Organizer
      第85回実験結核研究会
    • Place of Presentation
      長崎ブリックホール第4会場
    • Year and Date
      2015-03-26
    • Related Report
      2014 Annual Research Report

URL: 

Published: 2014-07-25   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi